FRC
FRC Logo
CommunityMarkets
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Company ProfileHumana Inc.
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
HUM
Humana Inc. Stock AnalysisComprehensive stock analysis for Humana Inc. (HUM) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisHUM
HUM
Humana Inc.
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
HUM
  1. Home
  2. Stocks
  3. Humana Inc.

Humana Inc.

🇺🇸HUM•NYSE

Humana Inc.

🇺🇸HUM•NYSE
Market cap
$55.38B
Sentiment

Your view on HUM

Mkt Cap
$55.38B
Sentiment
Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Humana Inc.

Industry
Medical - Healthcare Plans
Sector
Healthcare
CEO
James A. Rechtin
Headquarters
Humana Building, Louisville, KY, US
Industry
Medical - Healthcare Plans
Sector
Healthcare
CEO
James A. Rechtin
Headquarters
Humana Building, Louisville, KY, US
Description

Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. It operates through three segments: Retail, Group and Specialty, and Healthcare Services. The company offers medical and supplemental benefit plans to individuals.

It also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.

In addition, the company provides commercial fully insured medical and specialty health insurance benefits comprising dental, vision, and other supplemental health benefits; and administrative services only products to individuals and employer groups, as well as military services, such as TRICARE T2017 East Region contract.

Further, it offers pharmacy solutions, provider services, and home solutions services, such as home health and other services to its health plan members, as well as to third parties.

As of December 31, 2021, the company had approximately 17 million members in medical benefit plans, as well as approximately 5 million members in specialty products. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.

Financial Data

Stock Data

Price chart, volume, and trading data.

What moved it

FRC Fair Value Algorithm

What the FRC Fair Value algorithm says it is worth vs. the current price — FRC's own, on every stock.

About this section

Fair value for Humana Inc. from FRC's valuation model, read against the market price. HUM last traded at $461.12, 44.4× trailing earnings — the estimate is read against that market price. The model runs on every stock on the platform and shows the estimate per share and the date it was calculated. A free account covers 3 company valuations a month; a paid subscription is unlimited.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

About this section

Valuation, profitability, liquidity and leverage ratios for Humana Inc.. Starting points for Humana Inc.: P/E 44.4, EPS $10.37, beta 0.74 — an Medical - Healthcare Plans name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

About this section

Dividend history, yield and payout sustainability for Humana Inc.. Humana Inc. paid $3.54 per share over the last year — a 0.8% yield at the current $461.12 price. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

About this section

Reported vs. expected earnings history for Humana Inc.. Trailing twelve-month EPS for Humana Inc. stands at $10.37. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Wall Street Analyst Estimates

Analysts' price targets, ratings, and revenue and EPS estimates.

Third partyAs of Nov 18, 2026 · USD

Price targets, ratings and estimates published by outside analysts. Not FRC research, not a recommendation, and not the FRC Fair Value: that is FRC's proprietary model, built on the cash a company generates.

Current price

—

live quote

Analysts' target

$483.74

average of 19 firms, last 12 months

 

$483.74

Low $300.00

Median $495.00

High $596.00

 

Analyst Ratings

Buy20 firms, last 12 months
  • Strong Buy0
  • Buy12
  • Hold7
  • Sell1
  • Strong Sell0

Earnings Estimate

EPSCurrent QtrDec 2026Next QtrMar 2027Current YearFY Dec 2026Next YearFY Dec 2027
Avg. estimate-$7.59$13.48$9.54$18.77
Low estimate-$7.83$10.09$9.10$12.25
High estimate-$6.66$17.23$10.49$24.75
No. of analysts16121516
Year-ago EPS-$3.96$10.31$9.84—
Growth-91.7%+30.7%-3.1%—

Revenue Estimate

RevenueCurrent QtrDec 2026Next QtrMar 2027Current YearFY Dec 2026Next YearFY Dec 2027
Avg. estimate$41.33B$43.39B$162.89B$173.99B
Low estimate$40.59B$40.09B$161.73B$159.62B
High estimate$42.50B$45.59B$164.15B$184.64B
No. of analysts1281216
Year-ago revenue$32.52B$39.65B$129.66B—
Growth+27.1%+9.4%+25.6%—
Recent analyst actions15 rating and price-target changes, latest Nov 17, 2026 — with the analyst, firm and source

Source: Wall Street analysts' published price targets, ratings and estimates, compiled by Financial Modeling Prep from StreetInsider, Benzinga, Pulse 2.0, MarketWatch; as of Nov 18, 2026. Not FRC research or a recommendation.

Financial Statements

Income statement, balance sheet, and cash flow statements.

About this section

Income statement, balance sheet and cash flow history for Humana Inc.. Humana Inc. has reported as a listed company since 1981. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Peers, the industry, and the funds that hold HUM13 companies · 8 funds
Compare HUM with its peers, side by sidePremiumRatios, margins, valuation and leverage of the peers below — one table, one glance.Open Comparable Analysis

Peer companies

Market cap

  • ALHCAlignment Healthcare, Inc.Medical - Healthcare Plans$1.6B
  • CIThe Cigna GroupMedical - Healthcare Plans$79.1B
  • CNCCentene CorporationMedical - Healthcare Plans$37.0B
  • CVSCVS Health CorporationMedical - Healthcare Plans$113.3B
  • ELVElevance Health Inc.Medical - Healthcare Plans$96.4B
  • MOHMolina Healthcare, Inc.Medical - Healthcare Plans$12.2B
  • OSCROscar Health, Inc.Medical - Healthcare Plans$8.1B

More Medical - Healthcare Plans companies

  • MRAIMarpai, Inc.OTC$9M
  • PFHOPacific Health Care Organization, Inc.OTC$17M
  • PGNYProgyny, Inc.NASDAQ$2.7B
  • UNHUnitedHealth Group IncorporatedNYSE$369.2B
  • UNH.NEUnitedHealth Group IncNEO
  • CLOVClover Health Investments, Corp.NASDAQ$2.6B

ETFs holding Humana Inc.

% of the fund

  • VOOVanguard S&P 500 ETF$1.0T in assets0.08%
  • VTIVanguard Total Stock Market ETF$689.2B in assets0.07%
  • VOVanguard Mid-Cap ETF$103.4B in assets0.48%
  • IVViShares Core SP 500 ETF$852.9B in assets0.08%
  • PINKSimplify Health Care ETF$352M in assets5.09%
  • IHFiShares US Healthcare Providers ETF$1.5B in assets4.78%
  • DXG.TODynamic Active Global Dividend ETF$825M in assets3.83%
  • RPVInvesco S&P 500 Pure Value ETF$1.8B in assets2.65%

Largest holders first, then the funds most concentrated in HUM.

Open Comparable Analysis
Ownership & News

Institutional Ownership

Which funds and firms own the stock.

About this section

Which institutions hold Humana Inc., and how their positions are changing. At a $55.38B market value, institutional positions materially move Humana Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.

Insider Trading

Recent buying and selling by company executives.

About this section

Buying and selling by Humana Inc. executives and directors. Shares of Humana Inc. have traded between $206.87 and $315.35 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.

Senate Trading

U.S. Senator disclosures filed under the STOCK Act.

About this section

U.S. Senate disclosures naming Humana Inc.. Humana Inc. is a $55.38B Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely.

House Trading

U.S. Representative disclosures filed under the STOCK Act.

About this section

U.S. House of Representatives disclosures naming Humana Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals.

News

Latest headlines and market coverage.

About this section

Latest headlines and company announcements for Humana Inc.. Coverage tracks Humana Inc. within Medical - Healthcare Plans (Healthcare). Press releases and market coverage, newest first.

Discussion

Comments

Comments and replies from FRC members about this company.

No comments yet

Be the first to ask a question or say what you make of Humana Inc.

HUM Analysis
Good
Past5
Growth5
Health3
Profit2
Value1

News

Latest Market News